Investigational Drug Information for Dapaconazole
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the development status for investigational drug Dapaconazole?
Dapaconazole is an investigational drug.
There have been 4 clinical trials for Dapaconazole.
The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2016.
The most common disease conditions in clinical trials are Tinea, Tinea Pedis, and Tinea cruris. The leading clinical trial sponsors are Biolab Sanus Farmaceutica, Galeno Desenvolvimento de Pesquisas Clínicas, and Gilberto De Nucci.
There are four US patents protecting this investigational drug and fifty-six international patents.
Summary for Dapaconazole
| US Patents | 4 |
| International Patents | 56 |
| US Patent Applications | 10 |
| WIPO Patent Applications | 7 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 3 (2016-06-01) |
| Vendors | 12 |
Recent Clinical Trials for Dapaconazole
| Title | Sponsor | Phase |
|---|---|---|
| Non-inferiority Trial of Dapaconazole Versus Ketoconazole | Biolab Sanus Farmaceutica | Phase 3 |
| Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis | Biolab Sanus Farmaceutica | Phase 3 |
| Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea Pedis | Biolab Sanus Farmaceutica | Phase 2 |
Clinical Trial Summary for Dapaconazole
Top disease conditions for Dapaconazole
Top clinical trial sponsors for Dapaconazole
US Patents for Dapaconazole
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Dapaconazole | See Plans and Pricing | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | See Plans and Pricing |
| Dapaconazole | See Plans and Pricing | Oral drug dosage forms having desired drug release profiles and uses thereof | Triastek, Inc. (Nanjing, CN) | See Plans and Pricing |
| Dapaconazole | See Plans and Pricing | Compartmented pharmaceutical dosage forms | Triastek, Inc. (Nanjing, CN) | See Plans and Pricing |
| Dapaconazole | See Plans and Pricing | Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same | Biolab Sanus Farmaceutical Ltda. (Sao Paulo, BR) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Dapaconazole
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Dapaconazole | Australia | AU2017261372 | 2036-05-05 | See Plans and Pricing |
| Dapaconazole | Canada | CA3023278 | 2036-05-05 | See Plans and Pricing |
| Dapaconazole | China | CN107847398 | 2036-05-05 | See Plans and Pricing |
| Dapaconazole | European Patent Office | EP3452003 | 2036-05-05 | See Plans and Pricing |
| Dapaconazole | European Patent Office | EP3981392 | 2036-05-05 | See Plans and Pricing |
| Dapaconazole | Hong Kong | HK1249728 | 2036-05-05 | See Plans and Pricing |
| Dapaconazole | Japan | JP2019520866 | 2036-05-05 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
